IL1B and Alzheimer disease: The MAPK pathway is the upstream signaling intermediate to many inflammatory cytokines such as TNF-α, IL-1β, IL-6, and prostaglandin E2 [72], and the blockage of this pathway could be beneficial for treating inflammatory diseases like chronic periodontitis and AD [73, 74].